A pioneering in vitro culture model of Alzheimer’s disease was established for the first time by researchers from the Genetics and Aging Research Unit at Massachusetts General Hospital (MGH), entitled “A three-dimensional human neural cell culture model of Alzheimer’s disease.” The study, which was recently published in the …
People living in regions with deprived, disadvantaged conditions have higher probabilities of suffering cognitive dysfunctions than those living in regions with more developed living conditions, according to a study from the University of Ulster in United Kingdom, led by Professor Helene McNulty. The results of the research based on Ireland data revealed…
Difficult decisions facing Alzheimer’s and other advanced dementia patients must be made with careful consideration for the health and well-being of patients and their caregivers. A report in Nutrition in Clinical Practice, entitled, “Gastrostomy Tube Placement in Patients With Advanced Dementia or Near End…
The Alzheimer’s Association recently awarded Jose Abisambra, assistant professor at the University of Kentucky and researcher at the Sanders-Brown Center on Aging, a $100,000 New Investigator Research Grant to fund his work into understanding the function of a brain protein that alters during the development of Alzheimer’s disease. The…
Amarantus BioScience Holdings, Inc. recently released promising results from the Lymphocyte Proliferation Test (LymPro Test®) blood diagnostic for Alzheimer’s disease (AD) LP-002 study. Amarantus is a biotechnology company focused on research and development of treatments and diagnostics for diseases related to neurodegenerative and apoptosis (programmed cell death) processes that contribute…
Muses Labs, based at Research Triangle Park in Raleigh, North Carolina, creates software-based systems to enable personalized therapy for the treatment of complex diseases. The company recently announced the development of its first offering for addressing Alzheimer’s disease. The combination therapy it implements is based on a broad understanding…
New diagnostics are currently being developed by researchers to help doctors ascertain risk factors for Alzheimer’s Disease before the onset of symptoms. A recent study showed that a brain scan lasting no longer than 5 minutes could potentially yield results indicative of dementia risk by determining…
Avanir Pharmaceuticals, Inc. will present their most-recent results from two clinical trials currently underway for treating conditions associated with Alzheimer’s disease (AD). The data is set to be presented at the American Neurological Association’s (ANA) Annual Meeting in Baltimore, Maryland, from October 12-14, 2014. The phase II clinical trial evaluated…
The 2014 Nobel prize in physiology or medicine was recently awarded to three scientists for their discovery of brains’ cells that report animals’ position in space, which therefore is being referred to as the brain’s “internal GPS.” The prize is divided between John O’Keefe, PhD, director of the Sainsbury…
The Massachusetts Institute of Technology (MIT) AgeLab recently joined forces with the Transamerica companies to discuss significant financial issues regarding patients suffering from Alzheimer’s and their families, as well as to initiate a framework for new guidelines in effectively serving clients facing the disease. The meeting recently took place at the “Financial…
Get regular updates to your inbox.